Saneca Pharmaceuticals made a net profit of EUR -3.60 mil with revenues of EUR 57.5 mil in 2019, up by 0% and up by 60.6%, respectively, compared to the previous year.
This translates into a net margin of -6.26%. Historically, between 2018 and 2019, the firm’s net margin reached a high of 0% in 2018 and a low of -6.26% in 2019. The average net margin in the last five years amounted to -3.13%.
On the operating level, the EBITDA margin reached -2.90% and EBIT amounted to -5.80% of sales in 2019.
You can see all the company’s data at Saneca Pharmaceuticals profile, or you can download a report on the company in the report section.
Helgi Library 
